Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
[1] The pivotal SURMOUNT clinical trial program, which evaluated tirzepatide for weight management in over 5,000 participants, did not identify leg pain as a statistically significant adverse event occurring at notably higher rates than placebo
Scheme 17
Patients on such combinations require regular monitoring of INR (International Normalized Ratio) to ensure safe clotting parameters
As a step therapy medication many insurance plans require patients to try phentermine (or another non-GLP-1 medication) before approving coverage for Wegovy or Zepbound
US$ 22.79
US$ 26.31
US$ 29.16
